SPHRF Stock Price, Chart, Stats & News

Starpharma Holdings Limited
Save
Starpharma Holdings Limited (SPHRF) does not currently pay a dividend.
197.84M
Market cap
–
Current P/E
344.83x
Forward P/E
SPHRF chart
About
Health care
Sector
Biotechnology
Industry
Starpharma Holdings Limited is a global biopharmaceutical firm dedicated to the investigation, advancement, and marketing of its proprietary dendrimer-based products for pharmaceutical, life science, and other diverse applications. Among its commercialized offerings is VivaGel, an antibiotic-free therapy designed for both preventing and managing bacterial vaginosis. The company's pipeline also features the VivaGel antiviral condom and VIRALEZE, an antiviral nasal spray.
Similar securities
Based on sector and market capitalization
Report issue





